Susquehanna International Group
ENFN

Susquehanna International Group’s Enfusion, Inc. ENFN Stock Holding History

Susquehanna International Group’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-66,724
Closed -$744K – 14025
2025
Q1 		$744K Sell
66,724
-140,451
-68% -$1.55M ﹤0.01% 8002
2024
Q4 		$2.13M Buy
207,175
+175,542
+555% +$1.7M ﹤0.01% 5171
2024
Q3 		$300K Buy
+31,633
New +$273K ﹤0.01% 9603
2024
Q2 		– Sell
-13,331
Closed -$123K – 13436
2024
Q1 		$123K Sell
13,331
-11,167
-46% -$98.3K ﹤0.01% 11077
2023
Q4 		$238K Buy
24,498
+2,915
+14% +$27.2K ﹤0.01% 10328
2023
Q3 		$194K Sell
21,583
-38,530
-64% -$366K ﹤0.01% 10267
2023
Q2 		$674K Buy
60,113
+31,343
+109% +$278K ﹤0.01% 7609
2023
Q1 		$302K Buy
+28,770
New +$317K ﹤0.01% 9701
2022
Q4 		– Sell
-21,237
Closed -$262K – 13929
2022
Q3 		$262K Sell
21,237
-54,726
-72% -$668K ﹤0.01% 10148
2022
Q2 		$776K Buy
+75,963
New +$839K ﹤0.01% 7157
2022
Q1 		– Sell
-18,544
Closed -$388K – 14159
2021
Q4 		$388K Buy
+18,544
New +$375K ﹤0.01% 9863

Other funds holding ENFN

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's ENFN Position: Q2 2025 in Review

Susquehanna International Group sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 66,724 shares — an estimated $744K sold.

Susquehanna International Group first reported a position in ENFN in Q4 2021 and held it in 11 quarters. The position peaked at $2.13M in Q4 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Susquehanna International Group reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 66,724 Enfusion, Inc. shares in Q2 2025, an estimated $744K.
  • Susquehanna International Group first reported a position in Enfusion, Inc. in Q4 2021 and held it in 11 quarters.
  • Susquehanna International Group's Enfusion, Inc. position peaked at $2.13M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.